Expertise in
2
conditions

Dr. Asher M. Marks

Hematology | Oncology
Yale New Haven Hospital
20 York St, 
New Haven, CT 
Expertise in
2
conditions
Yale New Haven Hospital
20 York St, 
New Haven, CT 

Overview

Asher Marks is a Hematologist and an Oncologist practicing medicine in New Haven, Connecticut.

Dr. Marks is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Glioma, Gliomatosis Cerebri, Ganglioglioma, and Brain Tumor.

He is actively involved in clinical research, co-authoring 37 peer reviewed articles and participating in 2 clinical trials.

Specialties

Hematology
Oncology

Licenses

Pediatric Hematology-Oncology in CT

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

Yale New Haven Hospital
20 York St, New Haven, CT 06510

Additional Areas of Focus

Dr. Marks has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Target Validation/Phase1 Study of BGB-290 in Combination With Temozolomide in Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas
A Target Validation/Phase1 Study of BGB-290 in Combination With Temozolomide in Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas
Enrollment Status: Active_not_recruiting
Publish Date: March 13, 2026
Intervention Type: Drug
Study Drugs: BGB-290, Temozolomide
Study Phase: Phase 1
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2025
Intervention Type: Drug, Other, Radiation
Study Drugs: Cyclophosphamide, Cisplatin, Vincristine, Vismodegib, Pemetrexed, Gemcitabine
Study Phase: Phase 2
View 1 Less Clinical Trial

37 Total Publications

Psychophysiological Responses in Virtual Reality for Assessing Current Nicotine Use and Future Addiction Risk Among Young Adults: Protocol for a Mixed Methods Study.
Psychophysiological Responses in Virtual Reality for Assessing Current Nicotine Use and Future Addiction Risk Among Young Adults: Protocol for a Mixed Methods Study.
Journal: JMIR research protocols
Published: December 11, 2025

Frequently Asked Questions about Dr. Asher M. Marks

How do I make an appointment with Dr. Asher M. Marks?

You can book an appointment with Dr. Asher M. Marks by calling their office at 203-200-2400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Asher M. Marks a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Asher M. Marks is classified as an Advanced expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Asher M. Marks specialize in?

While Dr. Asher M. Marks is a Hematology, they have specific expertise in Glioma, Gliomatosis Cerebri, and Ganglioglioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Asher M. Marks participate in research or clinical trials?

Yes. Dr. Asher M. Marks has published 37 articles and abstracts on conditions like Glioma. You can view a list of Dr. Asher M. Marks's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Asher M. Marks accept my insurance?

Dr. Asher M. Marks accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 203-200-2400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Marks's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile